GoodRx Holdings to Showcase Commitment at J.P. Morgan Healthcare Conference 2025

GoodRx Holdings to Participate in J.P. Morgan Healthcare Conference

GoodRx Holdings, Inc., a leader in the U.S. prescription savings sector, announces its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. The company’s engagement in this prestigious event highlights its ongoing commitment to the healthcare industry and its role in shaping the future of medication affordability. Scheduled for 9:45 a.m. Pacific Time in San Francisco, the event will feature a fireside chat that offers insights into GoodRx's operations and its impact on consumers and healthcare professionals alike. The discussion will be accessible via a live webcast on GoodRx’s Investor Relations website, allowing a broad audience to engage with the company’s vision and achievements.

GoodRx’s presence at the conference serves as a platform to emphasize its mission of providing prescription savings to millions. Trusted by over 25 million consumers and 750,000 healthcare professionals annually, the company has facilitated significant savings on both generic and brand-name medications across more than 70,000 pharmacies nationwide. Since its inception in 2011, GoodRx has enabled consumers to save over $75 billion on prescription costs, showcasing its pivotal role in making healthcare more affordable and accessible. The upcoming fireside chat presents an opportunity for GoodRx to reinforce its leadership position in the prescription savings landscape and discuss future initiatives aimed at enhancing consumer access to medications.

The company’s proactive approach to investor relations is particularly noteworthy. GoodRx encourages current and potential investors to utilize its website for crucial updates and information, which will be disclosed in accordance with Regulation FD. This commitment to transparency not only fosters trust among investors but also aligns with GoodRx’s overall mission of empowering consumers in managing healthcare costs. GoodRx plans to continue providing updates through various channels, including press releases, SEC filings, and public conference calls, ensuring that stakeholders remain informed about its strategic direction and performance.

In addition to its participation in the J.P. Morgan Healthcare Conference, GoodRx maintains a strong focus on innovation and service enhancement. The company's commitment to improving healthcare affordability is evident in its continuous efforts to refine its platform and expand its partnerships within the healthcare ecosystem. By leveraging technology and data analytics, GoodRx strives to develop solutions that meet the evolving needs of consumers and healthcare providers.

Overall, GoodRx Holdings is poised to make a significant impact at the upcoming conference, reinforcing its dedication to prescription savings and consumer empowerment in the healthcare space. The company's transparent communication strategy and ongoing commitment to innovation underline its role as a trusted partner in the healthcare journey for millions of Americans.